Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study

Clinical significance of serum fibroblast growth factor 23 as a surrogate marker of the cardiorenal hemodynamic state in patients with heart failure

(2014) M. Imazu et al.   EUROPEAN HEART JOURNAL

The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study

(2013) Benjamin D. Parker   ANNALS OF INTERNAL MEDICINE

FGF23: A Mature Renal and Cardiovascular Risk Factor?

(2013) Carmine Zoccali et al.   BLOOD PURIFICATION

Serum FGF23 and Risk of Cardiovascular Events in Relation to Mineral Metabolism and Cardiovascular Pathology

(2013) J. Arnlov et al.   Clinical Journal of the American Society of Nephrology

Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study

(2013) Brian Buijsse et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Plasma 25-Hydroxyvitamin D and Its Genetic Determinants in Relation to Incident Myocardial Infarction and Stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study

(2013) Tilman Kühn et al.   PLoS One

Serum Level of the Phosphaturic Factor FGF23 Is Associated with Abdominal Aortic Calcification in Men: The STRAMBO Study

(2012) M. Schoppet et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ASSOCIATION OF FIBROBLAST GROWTH FACTOR (FGF)-23 LEVELS WITH RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

(2012) Jacob A. Udell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

(2012) Joachim H. Ix et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

FGF-23: the rise of a novel cardiovascular risk marker in CKD

(2012) G. H. Heine et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Reliability of plasma fibroblast growth factor 23 as risk biomarker in epidemiological studies measured over a four-month period

(2012) R. di Giuseppe et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

(2011) Eric N. Taylor et al.   AMERICAN HEART JOURNAL

Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study

(2011)   DIABETOLOGIA

DAGitty

(2011) Johannes Textor et al.   EPIDEMIOLOGY

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease

(2011) M. H. de Borst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

'Dem bones' are made for more than walking

(2011) L Darryl Quarles   NATURE MEDICINE

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status

(2010) Terry KW Ma et al.   BRITISH JOURNAL OF PHARMACOLOGY

Left ventricular hypertrophy: An overlooked cardiovascular risk factor

(2010) M. A. BAUML et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Minireview: Fibroblast Growth Factor 23 in Phosphate Homeostasis and Bone Metabolism

(2010) Michiko Hori et al.   ENDOCRINOLOGY

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

(2010) M. Wolf   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

(2008) Cornelia Weikert et al.   CIRCULATION